BN

Brad Niles, PhD

Chief Executive Officer

ARIZ Precision Medicine

Therapeutic Areas

ARIZ Precision Medicine Pipeline

DrugIndicationPhase
PRDM2 TargetLung CancerPreclinical
PRDM14 TargetBreast CancerPreclinical
PRDM1 TargetColon CancerPreclinical
PRDM16 TargetLeukemiaDiscovery